Acknowledging the kind of traction gained by this market, recently published a study report asserts the global East Africa and Turkey Heart Failure Drugs Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of around 17.79% during the review period (2022 to 2027).
Drug manufacturers have been motivated to create better treatment options because of heart failure ailment and especially because those treatment options will be well received in a market where there are growing number of cases each year.
In congestive heart failure, commonly known as heart failure heart muscle’s pumping ability is compromised. There are certain symptoms of heart failure like rapid and irregular heartbeat, swelling in ankles, feet and legs, shortness in breathing while lying down or exerting, constant coughing, sudden gain in weight due to retention of fluid, swelling in abdomen, loss of appetite and more. Few medical conditions like narrowing of the heart’s arteries or high blood pressure gradually weakens heart making the pumping difficult.
Power Station is the key application of Healthcare IT, which held 4/5 of the market in 2019.
Above than 1MW took about half of the market in 2019, which is the largest of all the types.
Industry News:
Novartis Entresto® granted expanded indication in chronic heart failure by FDA
Basel, February 16, 2021 —
Novartis today announced that the US Food and Drug Administration (FDA) has approved the following expanded indication for Entresto® (sacubitril/valsartan): to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure1. Benefits are most clearly evident in patients with left ventricular ejection fraction (LVEF) below normal1. The label also states LVEF is a variable measure and clinical judgment should be used in deciding whom to treat1.
By Type, it is segmented into
The global market is dominated by the North America region owing to the high adoption of pharmaceutical products, favorable government initiatives, and increasing healthcare expenditure in this region. The Asia Pacific region is expected to witness lucrative growth over the forecast period due to rising awareness about cardiovascular diseases and growing disposable income. Moreover, a large number of key players are based in Asian countries such as China & India which has led to an increase in product availability at lower prices., Key Companies & Brands (Takeda Pharmaceuticals U.S. LLC., Cipla Inc., Dr Reddy’s Laboratories Ltd.), Competitive Landscape (Competitive rivalry among companies depends on various factors such as product portfolio, sales strategy adopted by each company, distribution channel etc.
All these factors greatly affect the East Africa and Turkey Heart Failure Drugs Market growth. It further aims at providing complete overview on detailed assessment of significant features of different industries including sales volume, market revenue, and demand size, sales growth, pricing analysis and changing market growth factors in regions such as Follows,
The East Africa and Turkey Heart Failure Drugs Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global East Africa and Turkey Heart Failure Drugs Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes
|
|
Report Details |
Forecast Period 2022 to 2028 CAGR |
|
CAGR of 17.79% during the review period (2022 to 2027). |
By Type |
|
|
By end user’s |
|
|
By Companies
|
| Novartis, Pfizer, AstraZeneca, Hikma, Teva, Cipla, Merck & Co., Amgen, Roche, Sun Pharma, Mylan, Amgen Inc. (U.S.), Boehringer Ingelheim International GmbH (Germany),, Johnson & Johnson Services, Inc. (U.K.),, Bristol-Myers Squibb Company (U.S.),, Merck Sharp & Dohme Corp. (U.S.), Inc., Gilead Sciences, Inc. (California),Bayer AG, , CRC Health, Exelixis, Inc., GlaxoSmithKline plc, Johnson & Johnson, Lunan Pharmaceuticals Co. Ltd., Merck & Co., Inc., Mylan N.V., Novartis AG, Sanofi S.A., Shanghai Haini Pharmaceutical Co., Ltd., Shanghai Xudong Haipu Pharmaceutical Co., Ltd., The National Council for Palliative Care, Valeant Pharmaceuticals International, Inc. and others. |
Regions Covered
|
|
|
Countries Covered |
|
|
Base Year
|
|
2022 |
Historical Year
|
|
2017 to 2021 |
Forecast Year
|
|
2022 to 2027 |
Number of Pages |
| 118 |
Customization Available
|
| Yes, the report can be customized as per your needs |
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
What is the study period of this market?
The East Africa and Turkey Heart Failure Drugs Market is studied from 2017 - 2027.
What is the growth rate of East Africa and Turkey Heart Failure Drugs Market?
The East Africa and Turkey Heart Failure Drugs Market is growing at a CAGR of 7.61% over the next 5 years.
Who are the key players in East Africa and Turkey Heart Failure Drugs Market?
Novartis, Pfizer, AstraZeneca, Hikma, Teva, Cipla, Merck & Co., Amgen, Roche, Sun Pharma, Mylan, Amgen Inc. (U.S.), Boehringer Ingelheim International GmbH (Germany),, Johnson & Johnson Services, Inc. (U.K.),, Bristol-Myers Squibb Company (U.S.),, Merck Sharp & Dohme Corp. (U.S.), Inc., Gilead Sciences, Inc. (California),Bayer AG, , CRC Health, Exelixis, Inc., GlaxoSmithKline plc, Johnson & Johnson, Lunan Pharmaceuticals Co. Ltd., Merck & Co., Inc., Mylan N.V., Novartis AG, Sanofi S.A., Shanghai Haini Pharmaceutical Co., Ltd., Shanghai Xudong Haipu Pharmaceutical Co., Ltd., The National Council for Palliative Care, Valeant Pharmaceuticals International, Inc. and others.
What region does this East Africa and Turkey Heart Failure Drugs Market report covers?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of East Africa and Turkey Heart Failure Drugs Market?
ACEI, Angiotensin II Receptor Blockers, ARNIs, Beta Blockers, Aldosterone Antagonists,Diuretics,Others
What are the major end-users of East Africa and Turkey Heart Failure Drugs Market?
Reduced Ejection Fraction, Preserved Ejection Fraction, Hospitals, Specialty Centers,Others
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.
